注意力缺陷多动障碍的药物干预：青少年及成年患者的信念和态度如何影响治疗依从性？
Pharmacological interventions for ADHD: how do adolescent and adult patient beliefs and attitudes impact treatment adherence?
作者信息
McCarthy Suzanne
机构信息
School of Pharmacy, University College Cork, Cork, Ireland.
出版信息
Patient Prefer Adherence. 2014 Sep 25;8:1317-27. doi: 10.2147/PPA.S42145. eCollection 2014.
Abstract
Adherence to medication can be problematic for patients, especially so for patients with attention deficit hyperactivity disorder (ADHD). Effective medications are available for the treatment of ADHD; however, nonadherence rates for ADHD medication range from 13.2%-64%. The reasons for nonadherence can be complex. This review aims to look at how the beliefs and attitudes of adolescents and adults impact ADHD treatment adherence.
摘要
坚持服药对患者来说可能是个问题，尤其是对患有注意力缺陷多动障碍（ADHD）的患者而言。有有效的药物可用于治疗ADHD；然而，ADHD药物的不依从率在13.2%至64%之间。不依从的原因可能很复杂。本综述旨在探讨青少年和成年人的信念和态度如何影响ADHD治疗的依从性。
相似文献
1
Pharmacological interventions for ADHD: how do adolescent and adult patient beliefs and attitudes impact treatment adherence?
Patient Prefer Adherence. 2014 Sep 25;8:1317-27. doi: 10.2147/PPA.S42145. eCollection 2014.
2
Review of medication adherence in children and adults with ADHD.
Postgrad Med. 2010 Jan;122(1):184-91. doi: 10.3810/pgm.2010.01.2112.
3
Beliefs regarding medication and side effects influence treatment adherence in adolescents with attention deficit hyperactivity disorder.
Eur Child Adolesc Psychiatry. 2017 May;26(5):559-571. doi: 10.1007/s00787-016-0919-1. Epub 2016 Nov 15.
4
Attention-Deficit/Hyperactivity Disorder Medication Use in Adolescents: The Patient's Perspective.
J Adolesc Health. 2017 Nov;61(5):619-625. doi: 10.1016/j.jadohealth.2017.05.027. Epub 2017 Sep 9.
5
Adherence, persistence, and medication discontinuation in patients with attention-deficit/hyperactivity disorder - a systematic literature review.
Neuropsychiatr Dis Treat. 2014 Aug 22;10:1543-69. doi: 10.2147/NDT.S65721. eCollection 2014.
6
A preliminary study of factors affecting adherence to medication in clinic children with attention-deficit/hyperactivity disorder.
Indian J Psychiatry. 2011 Jan;53(1):41-4. doi: 10.4103/0019-5545.75561.
7
Exploring Factors Influencing Medication Adherence From Initiation to Discontinuation in Parents and Adolescents With Attention Deficit Hyperactivity Disorder.
Clin Pediatr (Phila). 2020 Mar;59(3):285-296. doi: 10.1177/0009922819900973. Epub 2020 Jan 24.
8
Impact of personality on adherence to and beliefs about ADHD medication, and perceptions of ADHD in adolescents.
BMC Psychiatry. 2020 Mar 30;20(1):139. doi: 10.1186/s12888-020-02543-x.
9
The Effects of Long-Acting Stimulant and Nonstimulant Medications in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Meta-Analysis of Randomized Controlled Trials.
J Child Adolesc Psychopharmacol. 2018 Oct;28(8):494-507. doi: 10.1089/cap.2017.0151. Epub 2018 Jun 13.
10
Medication therapy for attention deficit/hyperactivity disorder is associated with lower risk of fracture: a retrospective cohort study.
Osteoporos Int. 2016 Jul;27(7):2223-2227. doi: 10.1007/s00198-016-3547-1. Epub 2016 Feb 29.
引用本文的文献
1
Medication adherence among Japanese patients with developmental disabilities: a survey study.
Front Psychiatry. 2024 Oct 21;15:1431604. doi: 10.3389/fpsyt.2024.1431604. eCollection 2024.
2
Review of barriers and interventions to promote treatment engagement for pediatric attention deficit hyperactivity disorder care.
World J Psychiatry. 2021 Dec 19;11(12):1206-1227. doi: 10.5498/wjp.v11.i12.1206.
3
The art and science of drug titration.
Ther Adv Drug Saf. 2021 Jan 19;11:2042098620958910. doi: 10.1177/2042098620958910. eCollection 2020.
4
Evaluating the reliability of hair analysis in monitoring the compliance of ADHD patients under treatment with Lisdexamphetamine.
PLoS One. 2021 Mar 30;16(3):e0248747. doi: 10.1371/journal.pone.0248747. eCollection 2021.
5
Prescribing of medication for attention deficit hyperactivity disorder among young people in the Clinical Practice Research Datalink 2005-2013: analysis of time to cessation.
Eur Child Adolesc Psychiatry. 2018 Jan;27(1):29-35. doi: 10.1007/s00787-017-1011-1. Epub 2017 Jun 6.
6
Factors affecting treatment adherence to atomoxetine in ADHD: a systematic review.
Neuropsychiatr Dis Treat. 2016 May 3;12:1061-83. doi: 10.2147/NDT.S97724. eCollection 2016.
7
Evaluating functional outcomes in adolescents with attention-deficit/hyperactivity disorder: development and initial testing of a self-report instrument.
Health Qual Life Outcomes. 2015 Aug 22;13:133. doi: 10.1186/s12955-015-0302-9.
本文引用的文献
1
Exploring stimulant treatment in ADHD: narratives of young adolescents and their parents.
BMC Psychiatry. 2014 Apr 12;14:110. doi: 10.1186/1471-244X-14-110.
2
Adherence to stimulants in adult ADHD.
Atten Defic Hyperact Disord. 2014 Jun;6(2):111-20. doi: 10.1007/s12402-014-0129-y. Epub 2014 Mar 7.
3
ADHD prevalence estimates across three decades: an updated systematic review and meta-regression analysis.
Int J Epidemiol. 2014 Apr;43(2):434-42. doi: 10.1093/ije/dyt261. Epub 2014 Jan 24.
4
Executive dysfunction in children affected by obstructive sleep apnea syndrome: an observational study.
Neuropsychiatr Dis Treat. 2013;9:1087-94. doi: 10.2147/NDT.S47287. Epub 2013 Aug 9.
5
Visuomotor competencies and primary monosymptomatic nocturnal enuresis in prepubertal aged children.
Neuropsychiatr Dis Treat. 2013;9:921-6. doi: 10.2147/NDT.S46772. Epub 2013 Jun 26.
6
Prevalence of parent-reported ASD and ADHD in the UK: findings from the Millennium Cohort Study.
J Autism Dev Disord. 2014 Jan;44(1):31-40. doi: 10.1007/s10803-013-1849-0.
7
Adult ADHD patient experiences of impairment, service provision and clinical management in England: a qualitative study.
BMC Health Serv Res. 2013 May 21;13:184. doi: 10.1186/1472-6963-13-184.
8
Intellectual disabilities and power spectra analysis during sleep: a new perspective on borderline intellectual functioning.
J Intellect Disabil Res. 2014 May;58(5):421-9. doi: 10.1111/jir.12036. Epub 2013 Mar 21.
9
Predictors and impact of non-adherence in adults with attention-deficit/hyperactivity disorder receiving OROS methylphenidate: results from a randomized, placebo-controlled trial.
BMC Psychiatry. 2013 Jan 24;13:36. doi: 10.1186/1471-244X-13-36.
10
Beliefs regarding stimulant medication effects among college students with a history of past or current usage.
J Atten Disord. 2014 Apr;18(3):247-57. doi: 10.1177/1087054712459755. Epub 2012 Oct 9.
Zotero 插件